Swiss firm licenses gene therapies from UMass Medical School

A Swiss company developing gene therapies for neurological diseases has licensed programs researched at UMass Medical School in Worcester.
The therapies are meant to treat Tay-Sachs and Sandhoff diseases, two rare and similar inherited conditions. Research on the therapies was developed by a team of researchers at UMass Medical School, including Miguel Sena-Esteves, Heather Gray-Edwards and Terence Flotte, the dean of the School of Medicine.